Diversification Re-engineered

Multi Asset Tactical View: November 2026

Jitters mostly below the surface

October: Rotation at play

October was a turbulent month for global equities, with Middle East tensions and renewed concerns over AI financing and valuations weighing on sentiment. These factors prompted a rotation from technology towards defensive and previously unloved areas. The UK and Europe posted modest gains, while the US edged lower, Japan underperformed and emerging markets fell sharply. Energy, consumer staples and health care advanced, while technology lagged. Global bonds recovered some of September’s losses as safe-haven demand lowered yields. Brent rose sharply on Hormuz supply risks, while gold fell below USD 3,900 as strong US data fuelled expectations of a December US Federal Reserve rate hike. Since month-end, some risks have been priced out: the clear US midterm results eased political uncertainty and oil retreated on hopes of de-escalation with Iran.

Our take: Selectively constructive

We remain constructive on global equities, as earnings have proven resilient, despite higher rates and renewed doubts about the AI investment cycle. In the US, the earnings backdrop remains supportive, but elevated valuations and concentration in AI-related stocks call for selectivity. We stay positive on Japan, backed by earnings upgrades and accommodative real rates, and maintain a modestly positive view on euro zone equities. Emerging markets continue to offer attractive valuations and earnings, despite greater sensitivity to the technology cycle.

In fixed income, we remain cautious based on systematic factors, although fundamentally yields are at increasingly attractive levels. Government bonds also provided renewed diversification during the recent equity sell-off. But sticky inflation and fiscal pressures caution against too constructive a stance for now. We also stay cautious on US high yield and emerging market hard-currency debt, despite some support from the economic backdrop. We remain constructive on commodities. Oil benefits from supply disruption, while constrained supply supports copper. We are more cautious on gold, as high real yields and a strong US dollar remain headwinds, despite longer-term support from central bank purchases and fiscal concerns. In currencies, we favour the dollar, supported by better carry, while stretched valuations limit further upside.

Tactical asset allocation views summary
These views reflect a short-term time horizon showing the direction and conviction of the team’s analysis based on both fundamental and systematic indicators. These views are independent of individual portfolio construction considerations.

Source: Bloomberg Finance L.P.; data as of 30 October 2026. Past performance does not predict future returns. Global equities are represented by MSCI AC World Daily TR, Global sovereign by FTSE World Government Bond Index – Developed Markets in USD, Commodities by Bloomberg Commodity Index, Currencies (USD) by Bloomberg Dollar Spot, US equities by S&P 500 Index, Euro-zone equities by MSCI EMU Index (EUR), Japanese equities by TOPIX Index (JPY), Emerging markets by MSCI EM NR, US treasuries by J.P. Morgan US Government Bond Index, UK gilts by J.P. Morgan UK Government Bond Index, Euro-zone sovereign by J.P. Morgan EMU Investment Grade Index, US high yield by Bloomberg U.S. Corporate High Yield, EM fixed income by J.P. Morgan EMBI Plus Index, Oil by S&P GSCI Crude Oil, Copper by BBG Copper TR, Gold by GOLD SPOT $/OZ. For currencies, the US dollar (USD) and the British pound (GBP) are represented by each respective currency vs. the euro (EUR) as well as the USD vs. the Japanese yen (JPY).

Theme of the Month: Biotech equities

Big pharma faces patent expiries that could affect more than USD 500 billion in drug sales between 2026 and 2032, peaking at USD 158bn in 2031. To rebuild pipelines drugmakers are buying biotech innovation: biopharma merger and acquisitions in the first half of 2026 nearly equaled the full-year 2025 total Yet biotech valuations remain below their long-term average, warranting a closer look at the sector.

Patent expiries: average annual sales at risk to more than double in 2026-2032 compared with 2014-2025

Source: Evaluate - 2014-2025: World Preview 2023 (June 2023); 2026-2032: Norstella forecasting data provided by Evaluate, as published by PharmaVoice (8 October 2026). M&A: IQVIA, "Biopharma M&A: Mid-year 2026 update" (8 July 2026; majority-stake deals of USD 250m or more). Valuation: FactSet, S&P Biotechnology Industry Index, 1-year forward P/E of 17.7x vs. 19.8x average since 1996, as at 30 June 2026. "Sales at risk" = worldwide prescription sales in the year before patent expiry, allocated to the year of expiry; it is potential exposure to generic competition, not expected revenue loss. Averages: USD 75bn a year in 2026-2032 vs. USD 34bn in 2014-2025; 2023-2025 values are forecasts from the 2023 edition and the two editions differ (e.g. 2027: USD 80bn vs. USD 44bn). Total 2026-2032: USD 527bn (sum of the plotted values). Curve: least-squares exponential fit through all plotted values (about 6% p.a.); a descriptive fit, not a forecast. Forecasts are not a reliable indicator of future results.

Chart of the month: Rotation, not yet capitulation
Defensive stocks took the lead as momentum reversed in October
MSCI World Momentum and Minimum Volatility indices, NTR USD, indexed (30 Sep 2026 = 100)

Source: Bloomberg Finance L.P., Allianz Global Investors, daily data from 30 Sep 2026 to 30 Oct 2026 as at 30 Oct 2026. Net total returns in USD, rebased to 100. Investors cannot invest directly in an index. The information above is provided for illustrative purposes only, it should not be considered a recommendation to purchase or sell any particular security or strategy or as investment advice. Past performance, or any prediction, projection or forecast does not predict future returns.

October saw a notable shift in equity factor leadership. The MSCI World Momentum Index, which has a significant tilt towards the technology and AI-related stocks that had led markets in recent months, fell 8.3% over the month, while the MSCI World Minimum Volatility Index gained 6.0%. The resulting gap of around 14 percentage points appears to reflect growing questions about whether the heavy investment in AI will deliver the expected returns, and pressure built towards month-end as tech earnings disappointed and equity volatility rose. Investors seemed to favour more defensive areas of the market, which tend to carry a larger weight in minimum volatility portfolios. As losses were largely concentrated in a relatively small group of large-cap names, the broader market proved more resilient than the headlines might suggest. While the sell-off points to increased nervousness, we would not necessarily read it as a fundamental turning point, as the longer-term case for AI still looks broadly supported in our view. The episode does, however, underline how strongly the market is currently focused on this single theme.

Disclosures The MSCI World Net Total Return Local Index is a free-float weighted equity index, and includes developed world markets. The FTSE World Government Bond Index- Developed Markets measures the performance of fixed-rate, local currency, investment-grade sovereign bonds issued in developed markets. The Bloomberg ex-Agriculture & Livestock Capped 6 Month Forward Index is a composite index that tracks the performance of commodities, excluding agriculture and livestock, with a capped allocation to ensure diversification. The Bloomberg Dollar Spot Index tracks the performance of a basket of ten leading global currencies versus the U.S. Dollar. The S&P 500® index includes 500 leading US-listed companies and captures approximately 80% coverage of available market capitalization. The TOPIX, also known as the Tokyo Stock Price Index, is a capitalization-weighted index of all companies listed on the First Section of the Tokyo Stock Exchange. The Bloomberg US Government Bond Index is comprised of the US Treasury and US Agency Indices. The J.P. Morgan EMU Government Bond Investment Grade (IG) Index aims to track the performance of eligible fixed-rate, euro-denominated domestic government debt issued by Eurozone countries with minimum €80 billion debt outstanding. Securities or issuers must be rated investment grade to be eligible. The J.P. Morgan EMBI Global Diversified Index tracks liquid, US Dollar emerging market fixed and floating-rate debt instruments issued by sovereign and quasi-sovereign entities. The Bloomberg Copper Subindex Total Return Index tracks the performance of copper futures. The USD-EUR Carry Return reflects the return from borrowing the short currency (EUR) to fund the purchase of the long currency (USD), while earning interest. The JPY-USD Carry Return reflects the return from borrowing the short currency (JPY) to fund the purchase of the long currency (USD), while earning interest. Unless otherwise noted, index returns reflect the reinvestment of income dividends and capital gains, if any, but do not reflect fees, brokerage commissions or other expenses of investing. It is not possible to invest directly in an index. Diversification does not guarantee a profit or protect against losses. Investing involves risk. The value of an investment and the income from it may fall as well as rise and investors might not get back the full amount invested. Past performance does not predict future returns. If the currency in which the past performance is displayed differs from the currency of the country in which the investor resides, then the investor should be aware that due to the exchange rate fluctuations the performance shown may be higher or lower if converted into the investor’s local currency. This is for information only and not to be construed as a solicitation or an invitation to make an offer to buy or sell any securities. The views and opinions expressed herein, which are subject to change without notice, are those of the issuer or its affiliated companies at the time of publication. The data used is derived from various sources and assumed to be accurate and reliable at the time of publication. but it has not been independently verified; its accuracy or completeness is not guaranteed and no liability is assumed for any direct or consequential losses arising from its use, unless caused by gross negligence or willful misconduct. The duplication, publication, extraction or transmission of the contents, irrespective of the form, is not permitted, except for the case of explicit permission by Allianz Global Investors. This material has not been reviewed by any regulatory authorities. This document is being distributed by the following Allianz Global Investors companies: In Australia, this material is presented by Allianz Global Investors Asia Pacific Limited (“AllianzGI AP”) and is intended for the use of investment consultants and other institutional/professional investors only, and is not directed to the public or individual retail investors. AllianzGI AP is not licensed to provide financial services to retail clients in Australia. AllianzGI AP is exempt from the requirement to hold an Australian Foreign Financial Service License under the Corporations Act 2001 (Cth) pursuant to ASIC Class Order (CO 03/1103) with respect to the provision of financial services to wholesale clients only. AllianzGI AP is licensed and regulated by Hong Kong Securities and Futures Commission under Hong Kong laws, which differ from Australian laws; in the European Union, by Allianz Global Investors GmbH, an investment company in Germany, authorized by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and is authorized and regulated in South Africa by the Financial Sector Conduct Authority; in the UK, by Allianz Global Investors (UK) Ltd. company number 11516839, authorised and regulated by the Financial Conduct Authority (FCA); in Switzerland, by Allianz Global Investors (Schweiz) AG, authorised by the Swiss financial markets regulator (FINMA); in HK, by Allianz Global Investors Asia Pacific Ltd., licensed by the Hong Kong Securities and Futures Commission; in Singapore, by Allianz Global Investors Singapore Ltd., regulated by the Monetary Authority of Singapore [Company Registration No. 199907169Z]; in Japan, by Allianz Global Investors Japan Co., Ltd., registered in Japan as a Financial Instruments Business Operator [Registered No. The Director of Kanto Local Finance Bureau (Financial Instruments Business Operator), No. 424], Member of Investment Management Association of Japan and Type II Financial Instruments Firms Association; In mainland China, it is for Qualified Domestic Institutional Investors scheme pursuant to applicable rules and regulations and is for information purpose only. in Taiwan, by Allianz Global Investors Taiwan Ltd., licensed by Financial Supervisory Commission in Taiwan; and in Indonesia, by PT. Allianz Global Investors Asset Management Indonesia licensed by Indonesia Financial Services Authority (OJK) and in the Abu Dhabi Global Market by Allianz Global Investors Middle East Limited, which is authorized and regulated by the ADGM Financial Services Regulatory Authority. AdMaster 6005626

Allianz Global Investors

You are leaving this website and being re-directed to the below website outside Hong Kong. This does not imply any approval or endorsement of the information by Allianz Global Investors contained in the redirected website nor does Allianz Global Investors accept any responsibility or liability in connection with this hyperlink and the information contained herein. Please keep in mind that the redirected website may contain funds and strategies not authorized for offering to the public of Hong Kong. Besides, please also take note of the redirected website's terms and conditions, privacy and security policies, and other legal information. By clicking "Continue", you confirm that you acknowledge the details mentioned above and would like to continue accessing the redirected website. Please click "Stay here" if you have any concerns.

Welcome to Allianz Global Investors

Select your language
  • 中文(繁體)
  • English
Select Role
  • Retail Investor
  • Institutional Investors
  • Pension Investors
  • Allianz Global Investors Fund (“AGIF”)

     • Allianz Global Investors Fund (“AGIF”) as an umbrella fund under the UCITS regulations has within it different Sub-Funds investing in fixed income securities, equities, and derivative instruments, each with a different investment objective and/or risk profile.

    • All Sub-Funds may invest in financial derivative instruments (“FDI”) which may expose to higher leverage, counterparty, liquidity, valuation, volatility, market and over the counter transaction risks. A Sub-Fund’s net derivative exposure may be up to 50% of its net asset value (“NAV”). 

    • Some Sub-Funds as part of their investments may invest in any one or a combination of the instruments such as fixed income securities, emerging market securities, and/or mortgage-backed securities, asset-backed securities, property-backed securities (especially REITs) and/or structured products and/or FDI, exposing to various potential risks (including leverage, counterparty, liquidity, valuation, volatility, market, fluctuations in the value of and the rental income received in respect of the underlying property, and over the counter transaction risks). 

    • Some Sub-Funds may invest in single countries or industry sectors (in particular small/mid cap companies) which may reduce risk diversification. Some Sub-Funds are exposed to significant risks which include investment/general market, country and region, emerging market (such as Mainland China), creditworthiness/credit rating/downgrading, default, asset allocation, interest rate, volatility and liquidity, counterparty, sovereign debt, valuation, credit rating agency, company-specific, currency (in particular RMB), RMB debt securities and Mainland China tax risks. 

    • Some Sub-Funds may invest in convertible bonds, high-yield, non-investment grade investments and unrated securities that may be subject to higher risks (including volatility, loss of principal and interest, creditworthiness and downgrading, default, interest rate, general market and liquidity risks) and therefore may adversely impact the net asset value of the Sub-Funds. Convertibles will be exposed prepayment risk, equity movement and greater volatility than straight bond investments.

    • Some Sub-Funds may invest a significant portion of the assets in interest-bearing securities issued or guaranteed by a non-investment grade sovereign issuer (e.g. Philippines) and is subject to higher risks of liquidity, credit, concentration and default of the sovereign issuer as well as greater volatility and higher risk profile that may result in significant losses to the investors. 

    • Some Sub-Funds may invest in European countries. The economic and financial difficulties in Europe may get worse and adversely affect the Sub-Funds (such as increased volatility, liquidity and currency risks associated with investments in Europe).

    • Some Sub-Funds may invest in the China A-Shares market, China B-Shares market and/or debt securities directly via the Stock Connect or the China Interbank Bond Market or Bond Connect or other foreign access regimes and/or other permitted means and/or indirectly through all eligible instruments and thus is subject to the associated risks (including quota limitations, change in rule and regulations, repatriation of the Sub-Fund’s monies, trade restrictions, clearing and settlement, China market volatility and uncertainty, China market volatility and uncertainty, potential clearing and/or settlement difficulties, change in economic, social and political policy in the PRC and Mainland China tax risks).  

    • Some Sub-Funds may adopt the following strategies, Socially Responsible Investment (Proprietary Scoring) Strategy, SDG-Aligned Strategy, Sustainability Key Performance Indicator Strategy (Relative), Green Bond Strategy, Multi Asset Sustainable Strategy, Sustainability Key Performance Indicator Strategy (Absolute Threshold), Environment, Social and Governance (“ESG”) Score Strategy, and Sustainability Key Performance Indicator Strategy (Absolute). The Sub-Funds may be exposed to sustainable investment risks relating to the strategies (such as foregoing opportunities to buy certain securities when it might otherwise be advantageous to do so, selling securities when it might be disadvantageous to do so, and/or relying on information and data from third party ESG research data providers and internal analyses which may be subjective, incomplete, inaccurate or unavailable and/or reducing risk diversifications compared to broadly based funds). Also, some Sub-Funds may be particularly focusing on the greenhouse gas emissions (“GHG”) efficiency of the investee companies rather than their financial performance. These may have an adverse impact on the performance of the Sub-Funds.

    • Some Sub-Funds may invest in share class with fixed distribution percentage (Class AMf). Investors should note that fixed distribution percentage is not guaranteed. The share class is not an alternative to fixed interest paying investment. The percentage of distributions paid by these share classes is unrelated to expected or past income or returns of these share classes or the Sub-Funds. Distribution will continue even the Sub-Fund has negative returns and may adversely impact the net asset value of the Sub-Fund.  Positive distribution yield does not imply positive return.

    • Investment involves risks that could result in loss of part or entire amount of investors’ investment.

    • In making investment decisions, investors should not rely solely on this [website/material].

     

     

    Note: Dividend payments may, at the sole discretion of the Investment Manager, be made out of the Sub-Fund’s capital or effectively out of the Sub-Fund’s capital which represents a return or withdrawal of part of the amount investors originally invested and/or capital gains attributable to the original investment. This may result in an immediate decrease in the NAV per share and the capital of the Sub-Fund available for investment in the future and capital growth may be reduced, in particular for hedged share classes for which the distribution amount and NAV of any hedged share classes (HSC) may be adversely affected by differences in the interests rates of the reference currency of the HSC and the base currency of the respective Sub-Fund, particularly if such HSC are applying the IRD Neutral Policy. Dividend payments are applicable for Class A/AM/AMg/AMi/AMgi/AQ Dis (Annually/Monthly/Quarterly distribution) and for reference only but not guaranteed.  Positive distribution yield does not imply positive return. For details, please refer to the Sub-Fund’s distribution policy disclosed in the offering documents.

     


    Allianz Global Investors Asia Fund

    • Allianz Global Investors Asia Fund (the “Trust”) is an umbrella unit trust constituted under the laws of Hong Kong pursuant to the Trust Deed. Allianz Thematic Income and Allianz Selection Income and Growth and Allianz Yield Plus Fund are the sub-funds of the Trust (each a “Sub-Fund”) investing in fixed income securities, equities and derivative instruments, each with a different investment objective and/or risk profile.

    • Some Sub-Funds are exposed to significant risks which include investment/general market, company-specific, emerging market, creditworthiness/credit rating/downgrading, default, volatility and liquidity, valuation, sovereign debt, thematic concentration, thematic-based investment strategy, counterparty, interest rate changes, country and region, asset allocation risks and currency (such as exchange controls, in particular RMB), and the adverse impact on RMB share classes due to currency depreciation.  

    • A Sub-Fund may invest in asset-backed securities (“ABS”) and mortgage-backed securities (“MBS”) which may be highly illiquid and prone to substantial price volatility. These instruments may be subject to greater general market risk, concentration risk, credit and counterparty default risk, liquidity risk and interest rate risk compared to other debt securities.

    • Some Sub-Funds may invest in high-yield (non-investment grade and unrated) investments and convertible bonds which may be subject to higher risks, such as volatility, creditworthiness, default, interest rate changes, general market and liquidity risks and therefore may  adversely impact the net asset value of the Sub-Fund. 

    • All Sub-Funds may invest in financial derivative instruments (“FDI”) which may expose to higher leverage, counterparty, liquidity, valuation, volatility, market and over the counter transaction risks.  The use of derivatives may result in losses to the Sub-Funds which are greater than the amount originally invested. A Sub-Fund’s net derivative exposure may be up to 50% of its net asset value (“NAV”).

    • These investments may involve risks that could result in loss of part or entire amount of investors’ investment.

    • In making investment decisions, investors should not rely solely on this website.

    Note: Dividend payments may, at the sole discretion of the Investment Manager, be made out of the Sub-Fund’s income and/or capital which in the latter case represents a return or withdrawal of part of the amount investors originally invested and/or capital gains attributable to the original investment. This may result in an immediate decrease in the NAV per distribution unit and the capital of the Sub-Fund available for investment in the future and capital growth may be reduced, in particular for hedged share classes for which the distribution amount and NAV of any hedged share classes (HSC) may be adversely affected by differences in the interests rates of the reference currency of the HSC and the base currency of the Sub-Fund, particularly if such HSC are applying the IRD Neutral Policy. Dividend payments are applicable for Class A/AM/AMg/AMi/AMgi Dis (Annually/Monthly distribution) and for reference only but not guaranteed.  Positive distribution yield does not imply positive return. For details, please refer to the Sub-Fund’s distribution policy disclosed in the offering documents.

Please indicate you have read and understood the Important Notice.